Drug · DIN 02362430
NAPROXEN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 13, 2013; first marketed March 18, 2011.
- Drug Identification Number (DIN)
- 02362430
- Company (DIN owner)
- Pharmascience Inc.Montreal, Quebec, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Naproxen M01AE02
- Class
- Human
- Record last updated
- June 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NAPROXEN SODIUM | 220 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 2, 2012: NOC 12995Abbreviated New Drug Submission (ANDS) · Manufacturer name change
- February 10, 2011: NOC 12062Abbreviated New Drug Submission (ANDS)
Other DINs named NAPROXEN
- DIN 02350750 · Cancelled Post Market
- DIN 02350769 · Cancelled Post Market
- DIN 02350777 · Cancelled Post Market
- DIN 02378418 · Cancelled Post Market
- DIN 02408759 · Cancelled Post Market